Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood

Clinical Study for Evaluation of Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood

The efficacy and safety of Autologous cultured keratinocyte cell on severe burn wound.

Inclusion Criteria:

• Age : 1~70 years
• More than 30% TBSA of second degree burn or more than 10% TBSA of third degree burn
• Must provide signed informed consent prior to participation in any study-related procedures

Exclusion Criteria:

• Have a pyogenic infection
• Part of the facial cosmetic surgery cost
• Hypersensitivity reactions in patients with bovine proteins
• Hypersensitivity reactions in patients with Gentamycin
• Pregnancy or lactation